Bibliographic Details
Title: |
263P Clinical outcomes in patients with germline pathogenic variants in homologous recombination repair (HRR) genes treated with CDK4/6 inhibitors (CDK4/6i) and endocrine therapy (ET) |
Authors: |
Rodriguez Hernandez, A., Martinez Saez, O., Brasó-Maristany, F., Pastor, B., Potrony, M., Moreno, L., Grau, E., Puig-Butille, J.A., Sánchez, A., Schettini, F., Conte, B., Chic, N., Vidal Losada, M.J., Munoz, M., Balaguer, F., Prat, A., Adamo, B. |
Source: |
In Annals of Oncology September 2022 33 Supplement 7:S657-S658 |
Database: |
ScienceDirect |